TCIM
OMED
TIAA CREF Investment Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-51,311
| Closed | -$473K | – | 3271 |
|
|
2017
Q1 | $473K | Sell |
51,311
-7,018
| -12% | -$64.7K | ﹤0.01% | 2807 |
|
|
2016
Q4 | $450K | Buy |
58,329
+1,043
| +2% | +$8.05K | ﹤0.01% | 2883 |
|
|
2016
Q3 | $655 | Buy |
57,286
+1,389
| +2% | +$16 | ﹤0.01% | 2744 |
|
|
2016
Q2 | $688K | Buy |
55,897
+2,294
| +4% | +$28.2K | ﹤0.01% | 2716 |
|
|
2016
Q1 | $542K | Sell |
53,603
-36,836
| -41% | -$372K | ﹤0.01% | 2765 |
|
|
2015
Q4 | $2.04M | Hold |
90,439
| – | – | ﹤0.01% | 2138 |
|
|
2015
Q3 | $1.5M | Sell |
90,439
-2,008
| -2% | -$33.3K | ﹤0.01% | 2320 |
|
|
2015
Q2 | $2.08M | Buy |
92,447
+12,506
| +16% | +$281K | ﹤0.01% | 2278 |
|
|
2015
Q1 | $2.06M | Buy |
79,941
+7,240
| +10% | +$187K | ﹤0.01% | 2201 |
|
|
2014
Q4 | $1.58M | Buy |
72,701
+7,473
| +11% | +$163K | ﹤0.01% | 2393 |
|
|
2014
Q3 | $1.24M | Sell |
65,228
-7,033
| -10% | -$133K | ﹤0.01% | 2518 |
|
|
2014
Q2 | $1.68M | Buy |
72,261
+59,581
| +470% | +$1.39M | ﹤0.01% | 2408 |
|
|
2014
Q1 | $427K | Hold |
12,680
| – | – | ﹤0.01% | 2985 |
|
|
2013
Q4 | $374K | Buy |
12,680
+2,600
| +26% | +$76.7K | ﹤0.01% | 3019 |
|
|
2013
Q3 | $154K | Buy |
+10,080
| New | +$154K | ﹤0.01% | 3068 |
|